Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -63.763% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: O=C(NCCCn1ccnc1)c1noc2c1CCCC2
b: COc1ccc(Cn2nnnc2C(c2ccc(C)cc2)N2CCN(C3CCCC3)CC2)cc1.Cl
c: Cc1ccccc1OCC(=O)Nc1ccc2c(c1)C(=O)c1ccccc1C2=O
d: Cc1nc2oc3ccc(F)cc3c(=O)c2cc1C(=O)O
e: COc1ccc(C(=O)C2CCCN(Cc3cnc(N4CCCC4)s3)C2)cc1OC
Answer: b. COc1ccc(Cn2nnnc2C(c2ccc(C)cc2)N2CCN(C3CCCC3)CC2)cc1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cn2nnnc2C(c2ccc(C)cc2)N2CCN(C3CCCC3)CC2)cc1.Cl
COc1ccc(Cn2nnnc2C(c2ccc(C)cc2)N2CCN(C3CCCC3)CC2)cc1.Cl
1-cyclopentyl-4-[[1-[(4-methoxyphenyl)methyl]tetrazol-5-yl]-(4-methylphenyl)methyl]piperazine;hydrochloride